Mary Ann Thenganatt, MD
Penn Medicine Clinician of Neurology
Department: Neurology
Contact information
330 S. 9TH STREET
PHILADELPHIA, PA 19107
PHILADELPHIA, PA 19107
Education
BA, MD (Medical Science, Medicine)
Boston University, 2006.
BA, MD (Medical Science, Medicine)
Boston University, 2006.
Post-Graduate Training
Intern, Internal Medicine, UCLA Medical Center, 2006-2007.
Resident, Neurology, Columbia University Medical Center, 2007-2010.
Movement Disorders Fellow, Neurology, Columbia University Medical Center, 2010-2012.
Intern, Internal Medicine, UCLA Medical Center, 2006-2007.
Resident, Neurology, Columbia University Medical Center, 2007-2010.
Movement Disorders Fellow, Neurology, Columbia University Medical Center, 2010-2012.
Certifications
American Board of Psychiatry and Neurology, 2010.
Permanent linkAmerican Board of Psychiatry and Neurology, 2010.
Selected Publications
Thenganatt MA, Jankovic J: The relationship between essential tremor and Parkinson's disease. Parkinsonism Relat Disord Suppl 1: S162-5, Jan 2016.Thenganatt MA, Jankovic J: Psychogenic Parkinsonism. Functional Neurological Disorders, Handbook of Neurology 2016 Notes: In press.
Thenganatt MA, Jankovic J: Botulinum toxin therapy for cervical dystonia. Treatment of Dystonia. Dressler D, Altenmuller E and Krauss J (eds.). 2016 Notes: In progress.
Thenganatt MA, Jankovic J: Recent advances in understanding/managing Tourette’s Syndrome F1000Res 592, August 2015.
Thenganatt MA, Jankovic J: Psychogenic movement disorders. Neurol Clin 33(1): 205-224, Feb 2015.
Thenganatt MA, Jankovic J : Parkinson Disease Subtypes. JAMA Neurol 71(4): 499-504, Apr 2014.
Thenganatt MA, Jankovic J : Treatment of dystonia. Neurotherapeutics 11(1): 139-52, Jan 2014.
Thenganatt MA, Louis ED: Personality profile in essential tremor: A case- control study. Parkinsonism Relat Disord 18(9): 1042-4, Nov 2012.
Thenganatt MA, Louis ED: Distinguishing essential tremor from Parkinson's disease: bedside tests and laboratory evaluations. Expert Rev Neurother 12(6): 687-96, Jun 2012.
Botulinum toxin for the treatment of movement disorders: Thenganatt MA, Fahn S. Curr Neurol Neurosci Rep 12(4): 399-409, Aug 2012.